SEC Form 4 · accession 0001209191-17-065495
Xylem Inc. · XYL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven R Loranger
Director
Period of report
Dec 11, 2017
Accepted (ET)
Dec 13, 2017 · 5:49 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001524472
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 11, 2017 | M | 196 | $32.38 | A | 21,327 | D | |
| Common StockF2 | Dec 11, 2017 | S | 196 | $68.23 | D | 21,131 | D | |
| Common Stock | holding | — | — | — | 130,918 | I | By Steven R. Loranger Revocable Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $32.38 | Dec 11, 2017 | M | 196 | D | — | Oct 31, 2018 | Common Stock | 196 | 65,051 | D |
Explanation of responses
- F1The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on November 10, 2017.
- F2This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $68.07 to $68.39 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- F3These options are fully vested and exercisable.